The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment

The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment

Abstract Background The full range of cardiovascular complications related to the use of Immune checkpoint inhibitors (ICI) is not fully understood. We aim to describe the spectrum of cardiovascular adverse events (cvAEs) by presenting our real-world experience of the diagnosis and management of the...

Full description

Bibliographic Details
Main Authors: Maria Sol Andres, Sivatharshini Ramalingam, Stuart D. Rosen, John Baksi, Rajdeep Khattar, Yulia Kirichenko, Kate Young, Nadia Yousaf, Alicia Okines, Robert Huddart, Kevin Harrington, Andrew J.S. Furness, Samra Turajlic, Lisa Pickering, Sanjay Popat, James Larkin, Alexander R. Lyon
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Cardio-Oncology
Subjects:
Cancer survivorship
Immunotherapy
Myocarditis
Cardiomyopathy
Online Access:https://doi.org/10.1186/s40959-022-00147-w

Internet

https://doi.org/10.1186/s40959-022-00147-w

Similar Items